

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 9.28204809 |
| 2 | drug catabolic process (GO:0042737) | 8.61849841 |
| 3 | exogenous drug catabolic process (GO:0042738) | 8.43493724 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.08291115 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.63808951 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.38140299 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.33243912 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.29458868 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.29458868 |
| 10 | regulation of protein activation cascade (GO:2000257) | 6.93756866 |
| 11 | complement activation, alternative pathway (GO:0006957) | 6.67219555 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 6.57973153 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.57973153 |
| 14 | cellular glucuronidation (GO:0052695) | 6.57076260 |
| 15 | urea metabolic process (GO:0019627) | 6.37717989 |
| 16 | serine family amino acid catabolic process (GO:0009071) | 6.31132527 |
| 17 | regulation of complement activation (GO:0030449) | 6.30496690 |
| 18 | drug metabolic process (GO:0017144) | 6.25043483 |
| 19 | glucuronate metabolic process (GO:0019585) | 6.24279925 |
| 20 | uronic acid metabolic process (GO:0006063) | 6.24279925 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.11445519 |
| 22 | protein carboxylation (GO:0018214) | 6.11445519 |
| 23 | bile acid biosynthetic process (GO:0006699) | 6.09508500 |
| 24 | oxidative demethylation (GO:0070989) | 6.05942336 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 6.01285420 |
| 26 | fibrinolysis (GO:0042730) | 6.00749189 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 5.95706060 |
| 28 | phenylpropanoid metabolic process (GO:0009698) | 5.92991519 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 5.79190484 |
| 30 | glycine metabolic process (GO:0006544) | 5.75960139 |
| 31 | ethanol oxidation (GO:0006069) | 5.70963138 |
| 32 | urea cycle (GO:0000050) | 5.49160968 |
| 33 | bile acid metabolic process (GO:0008206) | 5.43597743 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 5.43242679 |
| 35 | negative regulation of sterol transport (GO:0032372) | 5.12703237 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 5.12703237 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 5.09169453 |
| 38 | bile acid and bile salt transport (GO:0015721) | 5.00906976 |
| 39 | hormone catabolic process (GO:0042447) | 4.87901491 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.72469948 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.68085178 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.68085178 |
| 43 | serine family amino acid metabolic process (GO:0009069) | 4.66739857 |
| 44 | ethanol metabolic process (GO:0006067) | 4.61030557 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.59611221 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.59611221 |
| 47 | alkaloid metabolic process (GO:0009820) | 4.51301804 |
| 48 | protein activation cascade (GO:0072376) | 4.45314211 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 4.31912683 |
| 50 | regulation of plasminogen activation (GO:0010755) | 4.27385087 |
| 51 | regulation of humoral immune response (GO:0002920) | 4.20696651 |
| 52 | steroid catabolic process (GO:0006706) | 4.18926681 |
| 53 | negative regulation of coagulation (GO:0050819) | 4.15327671 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.13056612 |
| 55 | negative regulation of wound healing (GO:0061045) | 4.13003545 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.12303315 |
| 57 | arginine metabolic process (GO:0006525) | 4.10873789 |
| 58 | phospholipid efflux (GO:0033700) | 4.07728700 |
| 59 | complement activation (GO:0006956) | 4.07669788 |
| 60 | acute-phase response (GO:0006953) | 4.01473535 |
| 61 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.97259364 |
| 62 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.97259364 |
| 63 | negative regulation of complement activation (GO:0045916) | 3.96238892 |
| 64 | cytolysis (GO:0019835) | 3.91309548 |
| 65 | complement activation, classical pathway (GO:0006958) | 3.89145382 |
| 66 | flavonoid metabolic process (GO:0009812) | 3.88196674 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.86141849 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 3.85442595 |
| 69 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.79934236 |
| 70 | serine family amino acid biosynthetic process (GO:0009070) | 3.79902290 |
| 71 | regulation of lipoprotein particle clearance (GO:0010984) | 3.78755914 |
| 72 | tryptophan catabolic process (GO:0006569) | 3.77717177 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.77717177 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.77717177 |
| 75 | xenobiotic metabolic process (GO:0006805) | 3.76111641 |
| 76 | cholesterol efflux (GO:0033344) | 3.73112774 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.71604616 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.71604616 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.71604616 |
| 80 | heme transport (GO:0015886) | 3.68586344 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 3.68239145 |
| 82 | positive regulation of hemostasis (GO:1900048) | 3.68239145 |
| 83 | cysteine metabolic process (GO:0006534) | 3.68191675 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.64657548 |
| 85 | drug transmembrane transport (GO:0006855) | 3.60827035 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60482844 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.60018499 |
| 88 | xenobiotic catabolic process (GO:0042178) | 3.59647446 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.54373852 |
| 90 | high-density lipoprotein particle remodeling (GO:0034375) | 3.52731240 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.49444914 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.46513618 |
| 93 | cofactor catabolic process (GO:0051187) | 3.46420109 |
| 94 | ketone body metabolic process (GO:1902224) | 3.44301359 |
| 95 | positive regulation of coagulation (GO:0050820) | 3.41719795 |
| 96 | drug transport (GO:0015893) | 3.41050514 |
| 97 | negative regulation of humoral immune response (GO:0002921) | 3.40697078 |
| 98 | glutamate metabolic process (GO:0006536) | 3.39415595 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.38849738 |
| 100 | sodium-independent organic anion transport (GO:0043252) | 3.33865144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.27802634 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.90790516 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.17878653 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.20380343 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.80949204 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55964156 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.00406706 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79759322 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.27233582 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97638483 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.93052251 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54437314 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37508053 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.25203341 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.24086230 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93831221 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.74211511 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55590038 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50478740 |
| 20 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.46192706 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45848411 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39163344 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35820699 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35748060 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31429766 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31216537 |
| 27 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.21920177 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21120484 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20985571 |
| 30 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.20305744 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20036910 |
| 32 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18661374 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18496332 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18401574 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18078563 |
| 36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.14562297 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12329554 |
| 38 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.11286920 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.10385964 |
| 40 | AR_20517297_ChIP-Seq_VCAP_Human | 1.09835110 |
| 41 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06489756 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05895476 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05421125 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00883111 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99771296 |
| 46 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.99324504 |
| 47 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97037290 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95866303 |
| 49 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.95327933 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94195227 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93105464 |
| 52 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92837242 |
| 53 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.92595823 |
| 54 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.92366232 |
| 55 | ERA_21632823_ChIP-Seq_H3396_Human | 0.90139368 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89892850 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87780351 |
| 58 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86642264 |
| 59 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86113711 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85840646 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85840646 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85797540 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84749501 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84522501 |
| 65 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84067724 |
| 66 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83403089 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83108433 |
| 68 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82397941 |
| 69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82397941 |
| 70 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.81879109 |
| 71 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.81647383 |
| 72 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.80547167 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80400678 |
| 74 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.80386312 |
| 75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80110566 |
| 76 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79748803 |
| 77 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.77481088 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76954923 |
| 79 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76877909 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76809727 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75923218 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75887826 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75377394 |
| 84 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.74751632 |
| 85 | NFYB_21822215_ChIP-Seq_K562_Human | 0.74419663 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.74414749 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74387991 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74374794 |
| 89 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.74074116 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73226475 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73136358 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72573735 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72414171 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72414171 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72265017 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 0.71880851 |
| 97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68993020 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68667190 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.67917239 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.67640266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.86396874 |
| 2 | MP0005360_urolithiasis | 6.07286399 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96834436 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 5.35274952 |
| 5 | MP0005365_abnormal_bile_salt | 5.11900821 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.90990876 |
| 7 | MP0003195_calcinosis | 4.74162752 |
| 8 | MP0003868_abnormal_feces_composition | 3.98894730 |
| 9 | MP0003252_abnormal_bile_duct | 3.89451717 |
| 10 | MP0009697_abnormal_copulation | 3.89383659 |
| 11 | MP0002876_abnormal_thyroid_physiology | 3.33204847 |
| 12 | MP0001666_abnormal_nutrient_absorption | 3.09076099 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.47565154 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.44039815 |
| 15 | MP0005332_abnormal_amino_acid | 2.24937726 |
| 16 | MP0001764_abnormal_homeostasis | 1.95954842 |
| 17 | MP0000609_abnormal_liver_physiology | 1.72163480 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.56250956 |
| 19 | MP0009840_abnormal_foam_cell | 1.53552273 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.47515460 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.34329375 |
| 22 | MP0005408_hypopigmentation | 1.28010778 |
| 23 | MP0001661_extended_life_span | 1.26643779 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.26131233 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.14107916 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.12921993 |
| 27 | MP0002132_abnormal_respiratory_system | 1.11082903 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.09734069 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.09306149 |
| 30 | MP0009785_altered_susceptibility_to | 1.02553909 |
| 31 | MP0000598_abnormal_liver_morphology | 1.02311063 |
| 32 | MP0008469_abnormal_protein_level | 0.96420314 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95667931 |
| 34 | MP0005376_homeostasis/metabolism_phenot | 0.88113343 |
| 35 | MP0009642_abnormal_blood_homeostasis | 0.87392864 |
| 36 | MP0009763_increased_sensitivity_to | 0.85813824 |
| 37 | MP0003638_abnormal_response/metabolism_ | 0.83031490 |
| 38 | MP0009764_decreased_sensitivity_to | 0.79678312 |
| 39 | MP0002168_other_aberrant_phenotype | 0.79413932 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.79152664 |
| 41 | MP0008872_abnormal_physiological_respon | 0.77808242 |
| 42 | MP0003186_abnormal_redox_activity | 0.77337739 |
| 43 | MP0000604_amyloidosis | 0.76730308 |
| 44 | MP0002254_reproductive_system_inflammat | 0.76080550 |
| 45 | MP0005395_other_phenotype | 0.75968130 |
| 46 | MP0005187_abnormal_penis_morphology | 0.75577201 |
| 47 | MP0005535_abnormal_body_temperature | 0.69295612 |
| 48 | MP0005671_abnormal_response_to | 0.67973772 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 0.65727311 |
| 50 | MP0005410_abnormal_fertilization | 0.64268618 |
| 51 | MP0005266_abnormal_metabolism | 0.62554471 |
| 52 | MP0000249_abnormal_blood_vessel | 0.58113147 |
| 53 | MP0000685_abnormal_immune_system | 0.57862498 |
| 54 | MP0006082_CNS_inflammation | 0.56611456 |
| 55 | MP0005058_abnormal_lysosome_morphology | 0.56005988 |
| 56 | MP0005025_abnormal_response_to | 0.55945521 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 0.55091937 |
| 58 | MP0001915_intracranial_hemorrhage | 0.53616646 |
| 59 | MP0001845_abnormal_inflammatory_respons | 0.53063619 |
| 60 | MP0004043_abnormal_pH_regulation | 0.52907118 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.52355456 |
| 62 | MP0008874_decreased_physiological_sensi | 0.51760176 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.50142922 |
| 64 | MP0003436_decreased_susceptibility_to | 0.49806206 |
| 65 | MP0001835_abnormal_antigen_presentation | 0.49656921 |
| 66 | MP0005670_abnormal_white_adipose | 0.49107666 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.48432837 |
| 68 | MP0001800_abnormal_humoral_immune | 0.48430696 |
| 69 | MP0003879_abnormal_hair_cell | 0.47464456 |
| 70 | MP0002928_abnormal_bile_duct | 0.46689915 |
| 71 | MP0002971_abnormal_brown_adipose | 0.46407907 |
| 72 | MP0005166_decreased_susceptibility_to | 0.46109698 |
| 73 | MP0004885_abnormal_endolymph | 0.45727496 |
| 74 | MP0002419_abnormal_innate_immunity | 0.45499123 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.45154003 |
| 76 | MP0003763_abnormal_thymus_physiology | 0.44675344 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.43486787 |
| 78 | MP0000372_irregular_coat_pigmentation | 0.43418677 |
| 79 | MP0005000_abnormal_immune_tolerance | 0.42935924 |
| 80 | MP0003690_abnormal_glial_cell | 0.42651208 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.42585523 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.42104747 |
| 83 | MP0003011_delayed_dark_adaptation | 0.42035826 |
| 84 | MP0003045_fibrosis | 0.40688976 |
| 85 | MP0005334_abnormal_fat_pad | 0.39477522 |
| 86 | MP0001851_eye_inflammation | 0.37829705 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.37646430 |
| 88 | MP0003878_abnormal_ear_physiology | 0.37646430 |
| 89 | MP0008873_increased_physiological_sensi | 0.36267944 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.36176527 |
| 91 | MP0002723_abnormal_immune_serum | 0.35950523 |
| 92 | MP0004130_abnormal_muscle_cell | 0.35251944 |
| 93 | MP0003075_altered_response_to | 0.35031350 |
| 94 | MP0003959_abnormal_lean_body | 0.34477766 |
| 95 | MP0002405_respiratory_system_inflammati | 0.34451293 |
| 96 | MP0001790_abnormal_immune_system | 0.33034771 |
| 97 | MP0005387_immune_system_phenotype | 0.33034771 |
| 98 | MP0003953_abnormal_hormone_level | 0.32317105 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.31367170 |
| 100 | MP0002148_abnormal_hypersensitivity_rea | 0.30825881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.93396825 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.83843113 |
| 3 | Complement deficiency (HP:0004431) | 7.29591965 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.24858135 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03052156 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 6.02265269 |
| 7 | Abnormality of complement system (HP:0005339) | 5.74581873 |
| 8 | Joint hemorrhage (HP:0005261) | 5.64465818 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.44355990 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.36838238 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.18347827 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.90449164 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34144975 |
| 14 | Glomerulonephritis (HP:0000099) | 4.28212116 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.02631066 |
| 16 | Delayed CNS myelination (HP:0002188) | 3.93483117 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.92651247 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 3.87463371 |
| 19 | Xanthomatosis (HP:0000991) | 3.86981538 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.76804849 |
| 21 | Hyperammonemia (HP:0001987) | 3.55401402 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.55229180 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.46720589 |
| 24 | Hyperglycinemia (HP:0002154) | 3.34344866 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33921510 |
| 26 | Spontaneous abortion (HP:0005268) | 3.14931827 |
| 27 | Fat malabsorption (HP:0002630) | 3.03602233 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.02304091 |
| 29 | Pulmonary embolism (HP:0002204) | 2.91326488 |
| 30 | Nephritis (HP:0000123) | 2.87135602 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80691607 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.80691607 |
| 33 | Rickets (HP:0002748) | 2.79137365 |
| 34 | Hyperbilirubinemia (HP:0002904) | 2.76529807 |
| 35 | Osteomalacia (HP:0002749) | 2.72340692 |
| 36 | Abnormal biliary tract physiology (HP:0012439) | 2.68580967 |
| 37 | Bile duct proliferation (HP:0001408) | 2.68580967 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60852693 |
| 39 | Steatorrhea (HP:0002570) | 2.57268006 |
| 40 | Gingival bleeding (HP:0000225) | 2.54695835 |
| 41 | Metabolic acidosis (HP:0001942) | 2.54345389 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54119973 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 2.52771052 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.49890010 |
| 45 | Hyperglycinuria (HP:0003108) | 2.49760169 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.49584379 |
| 47 | Glycosuria (HP:0003076) | 2.49584379 |
| 48 | Menorrhagia (HP:0000132) | 2.45929075 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.44931722 |
| 50 | Arthropathy (HP:0003040) | 2.40839998 |
| 51 | Neonatal hypoglycemia (HP:0001998) | 2.37738982 |
| 52 | Ketosis (HP:0001946) | 2.37539861 |
| 53 | Fair hair (HP:0002286) | 2.33807272 |
| 54 | Thrombophlebitis (HP:0004418) | 2.27429757 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.26766870 |
| 56 | Abnormality of vitamin metabolism (HP:0100508) | 2.25721306 |
| 57 | Joint swelling (HP:0001386) | 2.23820252 |
| 58 | Elevated alkaline phosphatase (HP:0003155) | 2.22981854 |
| 59 | Purpura (HP:0000979) | 2.22648295 |
| 60 | Gangrene (HP:0100758) | 2.22261557 |
| 61 | Cholelithiasis (HP:0001081) | 2.19408765 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.14268065 |
| 63 | Cholecystitis (HP:0001082) | 2.14268065 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13918205 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.10852188 |
| 66 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08254796 |
| 67 | Vascular calcification (HP:0004934) | 2.06371166 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.01935570 |
| 69 | Hypochromic anemia (HP:0001931) | 2.00776405 |
| 70 | Deep venous thrombosis (HP:0002625) | 10.1012316 |
| 71 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.99077511 |
| 72 | Epidermoid cyst (HP:0200040) | 1.96161078 |
| 73 | Abnormal urine phosphate concentration (HP:0012599) | 1.94963625 |
| 74 | Cerebral palsy (HP:0100021) | 1.93541826 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91812349 |
| 76 | Hemorrhage of the eye (HP:0011885) | 1.91759610 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 1.89985712 |
| 78 | Poikilocytosis (HP:0004447) | 1.89964821 |
| 79 | Hypercholesterolemia (HP:0003124) | 1.89894115 |
| 80 | Pancreatitis (HP:0001733) | 1.88755748 |
| 81 | Epistaxis (HP:0000421) | 1.86684475 |
| 82 | Hypophosphatemia (HP:0002148) | 1.86335961 |
| 83 | Alkalosis (HP:0001948) | 1.84175102 |
| 84 | Lethargy (HP:0001254) | 1.82720339 |
| 85 | Renal cortical cysts (HP:0000803) | 1.82624932 |
| 86 | Irritability (HP:0000737) | 1.82382648 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 1.80712732 |
| 88 | Mitral stenosis (HP:0001718) | 1.79269798 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.77437262 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 1.76206981 |
| 91 | Submucous cleft hard palate (HP:0000176) | 1.75263934 |
| 92 | Cardiovascular calcification (HP:0011915) | 1.71960424 |
| 93 | Increased serum ferritin (HP:0003281) | 1.71591214 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.66428238 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65367264 |
| 96 | Azoospermia (HP:0000027) | 1.64636544 |
| 97 | Anorexia (HP:0002039) | 1.62177049 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 1.61246361 |
| 99 | Hypophosphatemic rickets (HP:0004912) | 1.59689528 |
| 100 | Cerebral edema (HP:0002181) | 1.59490784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.01715148 |
| 2 | MUSK | 3.73125075 |
| 3 | PINK1 | 3.29797551 |
| 4 | AKT3 | 3.25665671 |
| 5 | MAP4K1 | 3.16828689 |
| 6 | TXK | 3.13992313 |
| 7 | PIK3CG | 3.00585876 |
| 8 | GRK6 | 2.93808684 |
| 9 | ERN1 | 2.22427932 |
| 10 | FES | 2.10608253 |
| 11 | TNK2 | 1.94799146 |
| 12 | BCKDK | 1.88994572 |
| 13 | PIK3CA | 1.71710165 |
| 14 | LATS1 | 1.67899258 |
| 15 | FRK | 1.64753097 |
| 16 | NUAK1 | 1.64088330 |
| 17 | PRKCQ | 1.61548804 |
| 18 | TYK2 | 1.61176747 |
| 19 | ZAP70 | 1.49625455 |
| 20 | INSRR | 1.40796077 |
| 21 | KDR | 1.38454857 |
| 22 | IKBKE | 1.36282175 |
| 23 | TBK1 | 1.36165673 |
| 24 | TESK2 | 1.35025798 |
| 25 | SYK | 1.25501695 |
| 26 | CSF1R | 1.24414359 |
| 27 | JAK1 | 1.20453344 |
| 28 | DAPK2 | 1.20163384 |
| 29 | ITK | 1.19724598 |
| 30 | MAP2K2 | 1.18066089 |
| 31 | KIT | 1.13282627 |
| 32 | MAP3K11 | 1.13184664 |
| 33 | MAPK12 | 1.10542985 |
| 34 | BTK | 1.10497106 |
| 35 | MAPK11 | 1.07954103 |
| 36 | IKBKB | 1.07065609 |
| 37 | MAP2K4 | 1.06662625 |
| 38 | MAP4K2 | 1.05102609 |
| 39 | PLK4 | 1.04845099 |
| 40 | PRKACG | 0.97398464 |
| 41 | CDK3 | 0.97061846 |
| 42 | TEC | 0.94924794 |
| 43 | ADRBK2 | 0.90394615 |
| 44 | BCR | 0.89574102 |
| 45 | MAP3K3 | 0.88156794 |
| 46 | CAMKK2 | 0.87875628 |
| 47 | LCK | 0.87788460 |
| 48 | MAP3K6 | 0.87434294 |
| 49 | RIPK1 | 0.85650049 |
| 50 | MAPK7 | 0.85270227 |
| 51 | JAK2 | 0.82711470 |
| 52 | LYN | 0.80957093 |
| 53 | BMPR2 | 0.80258883 |
| 54 | MAP3K5 | 0.78365921 |
| 55 | CDK6 | 0.77178190 |
| 56 | PDK1 | 0.76449045 |
| 57 | GRK1 | 0.76068971 |
| 58 | MAP3K12 | 0.76029200 |
| 59 | VRK1 | 0.75603106 |
| 60 | IGF1R | 0.73820965 |
| 61 | MAP3K14 | 0.73527318 |
| 62 | FGFR4 | 0.73194158 |
| 63 | SGK2 | 0.71651694 |
| 64 | FGFR3 | 0.71410056 |
| 65 | CDK4 | 0.69677836 |
| 66 | BLK | 0.68988889 |
| 67 | PRKG1 | 0.66582916 |
| 68 | MATK | 0.64691987 |
| 69 | MAP2K3 | 0.62358800 |
| 70 | PRKAA2 | 0.58843966 |
| 71 | HCK | 0.58093009 |
| 72 | MAP3K7 | 0.57568174 |
| 73 | PIM1 | 0.56974487 |
| 74 | PRKCG | 0.55744143 |
| 75 | ZAK | 0.54772041 |
| 76 | PDPK1 | 0.54633432 |
| 77 | CSK | 0.54489280 |
| 78 | PRKACA | 0.53919853 |
| 79 | PRKCB | 0.52328644 |
| 80 | MAPK4 | 0.52152960 |
| 81 | PRKG2 | 0.51876388 |
| 82 | PRKCA | 0.51527744 |
| 83 | JAK3 | 0.49392886 |
| 84 | ABL2 | 0.47720448 |
| 85 | BRAF | 0.47156211 |
| 86 | MAPK15 | 0.46449363 |
| 87 | PRKCZ | 0.46414862 |
| 88 | SGK223 | 0.45101709 |
| 89 | SGK494 | 0.45101709 |
| 90 | CSNK1A1 | 0.44946168 |
| 91 | MAPK3 | 0.43794170 |
| 92 | PRKD3 | 0.42852377 |
| 93 | PRKCE | 0.41594605 |
| 94 | SGK3 | 0.40299665 |
| 95 | MST1R | 0.40130605 |
| 96 | PBK | 0.40050953 |
| 97 | TIE1 | 0.39975569 |
| 98 | SGK1 | 0.37929587 |
| 99 | NLK | 0.36629400 |
| 100 | RPS6KA3 | 0.36300465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30860814 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.95190509 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.59824823 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.53759690 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.52700041 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.43658637 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41351142 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.10352367 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.03877406 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.00285226 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.97188193 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.78574116 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.71814041 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52178067 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51744227 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47284121 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16715236 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05438400 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.00157545 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.99526188 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.98029668 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.86375766 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78800815 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67843780 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64355434 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.61083762 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52211725 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49687092 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44373662 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37226678 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26383151 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25665656 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23716867 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19940086 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17121794 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15051961 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14428602 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99557846 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97554855 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93534246 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88958161 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81571872 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79050824 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77200267 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75071978 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74549630 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74519185 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74201685 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72933535 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71529228 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70125960 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69599893 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.68828355 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.67338828 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52397338 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51685637 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44894949 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36282484 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35435901 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34379665 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.31175106 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30657481 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29515014 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26917970 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.25039888 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21832480 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.18096767 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17676082 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.16399515 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15222009 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.13493644 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13007995 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.10276512 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09663147 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.06269275 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05394829 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04043185 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03957618 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03627934 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00854531 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00741725 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.1608872 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1571295 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1468660 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1358300 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | -0.1343022 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1195603 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.1101549 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.1079704 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1071816 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1069950 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0955898 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | -0.0948665 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0790751 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | -0.0719147 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0687022 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0406582 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0345912 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0224564 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0089331 |

